Dianjie Li

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Demographic science aids in understanding the spread and fatality rates of COVID-19 2020 Jennifer B. Dowd
Liliana Andriano
David M. Brazel
Valentina Rotondi
Per Block
Xuejie Ding
Yan Liu
Melinda Mills
3
+ Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis 2020 Wei-jie Guan
Wenhua Liang
Yi Zhao
Heng-rui Liang
Zi‐Sheng Chen
Yi-min Li
Xiaoqing Liu
Ru-chong Chen
Chun-li Tang
Tao Wang
3
+ PDF Chat Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics 2020 Eskild Petersen
Marion Koopmans
Un-Yeong Go
Davidson H. Hamer
Nicola Petrosillo
Francesco Castelli
Merete Storgaard
Sulien Al Khalili
Lone Simonsen
2
+ PDF Chat Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response 2020 Ashish Goyal
E. FabiĂĄn Cardozo-Ojeda
Joshua T. Schiffer
1
+ PDF Chat SciPy 1.0: fundamental algorithms for scientific computing in Python 2020 Pauli Virtanen
Ralf Gommers
Travis E. Oliphant
Matt Haberland
Tyler Reddy
David Cournapeau
Evgeni Burovski
Pearu Peterson
Warren Weckesser
J.D. Bright
1
+ PDF Chat Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England 2020 Nicholas G. Davies
Sam Abbott
Rosanna C. Barnard
Christopher Jarvis
Adam J. Kucharski
James D. Munday
Carl A. B. Pearson
Timothy Russell
Damien C. Tully
Alex Washburne
1
+ Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort 2021 NadĂšge NĂ©ant
Guillaume Lingas
Quentin Le Hingrat
Jade Ghosn
Ilka Engelmann
Quentin Lepiller
Alexandre Gaymard
Virginie Ferré
CĂ©dric Hartard
Jean‐Christophe Plantier
1
+ PDF Chat Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England 2021 Nicholas G. Davies
Sam Abbott
Rosanna C. Barnard
Christopher I Jarvis
Adam J. Kucharski
James D. Munday
Carl A. B. Pearson
Timothy Russell
Damien C. Tully
Alex Washburne
1
+ A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 2021 Kwang Su Kim
Keisuke Ejima
Shoya Iwanami
Yasuhisa Fujita
Hirofumi Ohashi
Yoshiki Koizumi
Yusuke Asai
Shinji Nakaoka
Koichi Watashi
Kazuyuki Aihara
1
+ PDF Chat Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection 2021 David S. Khoury
Deborah Cromer
Arnold Reynaldi
Timothy E. Schlub
Adam K. Wheatley
Jennifer A. Juno
Kanta Subbarao
Stephen J. Kent
James A. Triccas
Miles P. Davenport
1
+ COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes 2021 Adrianne L. Jenner
Rosemary A. Aogo
Sofia Alfonso
Vivienne Crowe
Xiaoyan Deng
Amanda Smith
Penelope A. Morel
Courtney L. Davis
Amber M. Smith
Morgan Craig
1
+ Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission 2021 David A. Swan
Ashish Goyal
Chloe Bracis
Mia Moore
Elizabeth M Krantz
Elizabeth R. Brown
Fabian Cardozo-Ojeda
Daniel B. Reeves
Fei Gao
Peter B. Gilbert
1
+ PDF Chat Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2 2021 Matan Levine-Tiefenbrun
Idan Yelin
Hillel Alapi
Rachel Katz
Esma Herzel
Jacob Kuint
Gabriel Chodick
Sivan Gazit
Tal Patalon
Roy Kishony
1
+ Data-driven multi-scale mathematical modeling of SARS-CoV-2 infection reveals heterogeneity among COVID-19 patients 2021 Shun Wang
Mengqian Hao
Zishu Pan
Jinzhi Lei
Xiufen Zou
1
+ In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness 2021 Ruian Ke
Carolin Zitzmann
David D. Ho
Ruy M. Ribeiro
Alan S. Perelson
1
+ PDF Chat CoV-Spectrum: analysis of globally shared SARS-CoV-2 data to identify and characterize new variants 2021 Chaoran Chen
Sarah Nadeau
Michael Yared
Philippe Voinov
Ning Xie
Cornelius Roemer
Tanja Stadler
1
+ PDF Chat Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study 2021 Raphael Sonabend
Lilith K. Whittles
Natsuko Imai
Pablo N. Perez‐Guzman
Edward Knock
Thomas Rawson
Katy A. M. Gaythorpe
Bimandra A Djaafara
Wes Hinsley
Richard G. FitzJohn
1
+ Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons 2021 Stephen M. Kissler
Joseph R Fauver
Christina Mack
Caroline G. Tai
Mallery I. Breban
Anne E. Watkins
Radhika M Samant
Deverick J. Anderson
Jessica Metti
Gaurav Khullar
1
+ PDF Chat A multicompartment mathematical model based on host immunity for dissecting COVID-19 heterogeneity 2022 Jianwei Li
Jianghua Wu
Jingpeng Zhang
Lu Tang
Heng Mei
Yu Hu
Fangting Li
1
+ PDF Chat Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms 2022 Budhaditya Chatterjee
Harshbir Singh Sandhu
Narendra M. Dixit
1
+ PDF Chat Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach 2022 Bhargava Kandala
Nele Plock
Akshita Chawla
Anna Largajolli
Seth Robey
Kenny J. Watson
Raj Thatavarti
Sheri Dubey
S. Y. Amy Cheung
Rik de Greef
1
+ PDF Chat Modelling of the Innate and Adaptive Immune Response to SARS Viral Infection, Cytokine Storm and Vaccination 2023 Cristina Leon
A. Tokarev
Anass Bouchnita
Vitaly Volpert
1
+ SARS-CoV-2 (COVID-19) by the numbers 2020 Yinon M. Bar-On
Avi I. Flamholz
Rob Phillips
Ron Milo
1
+ PDF Chat Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study 2020 Shufa Zheng
Jian‐Gao Fan
Fei Yu
Baihuan Feng
Bin Lou
Qianda Zou
Guoliang Xie
Sha Lin
Ruonan Wang
Xianzhi Yang
1